MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10620-017-4860-z

Медицинская библиотека · Digestive diseases and sciences · 2018

Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective Study.

Benbow Jennifer H, Elam April D, Bossi Krista L, Massengill Danae L, Brandon-Warner Elizabeth, Anderson William E, Culberson Catherine R, Russo Mark W, deLemos Andrew S, Schrum Laura W

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIM: Hepatitis C virus (HCV)-related cirrhosis, one of the most common etiologies of liver cirrhosis in the Western world, is a risk factor for hepatocellular carcinoma. To confirm and improve current effectiveness of screening and prognosis of patients with established cirrhosis, a credible, simple plasma biomarker is needed. Hepatic stellate cell activation, a pivotal event in cirrhosis development, results in increased secretion of extracellular matrix proteins, including tenascin-C (TnC). Herein, we tested TnC as a simple biomarker to identify cirrhotic patients with active HCV infection from those with HCV eradication.

METHODS

A prospective study of subjects with HCV-related cirrhosis, stratified into two groups, HCV or virologic cure, was conducted. Plasma TnC expression was measured by ELISA and Western blots. TnC values were correlated with markers of liver injury and ROC analyses performed between groups.

RESULTS

The HCV cirrhotic cohort, consisting mostly of men (56%), Caucasians (76%), and genotype 1a or 1b (84%), was compared to healthy controls (HCs). Plasma TnC was significantly higher in HCV cirrhotic patients with active infection compared to HCs (P < 0.0001) and virologic cure (P < 0.0001). TnC concentrations in virologic cure subjects were not statistically different from HCs. TnC levels correlated with AST, platelets, MELD, APRI, FIB-4, and Child-Pugh score. TnC and AST together were significantly better indicators of cirrhosis in patients with active HCV infection than other markers tested.

CONCLUSIONS

TnC and AST provided the best model for discriminating HCV cirrhotics with active infection from HC and virologic cure cohorts over current liver injury markers, suggesting TnC as a potential indicator of ongoing hepatic injury and inflammation.

Для цитирования: Benbow Jennifer H, Elam April D, Bossi Krista L, Massengill Danae L, Brandon-Warner Elizabeth, Anderson William E, Culberson Catherine R, Russo Mark W, deLemos Andrew S, Schrum Laura W. Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective Study.. Digestive diseases and sciences. 2018. DOI: 10.1007/s10620-017-4860-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.